In Entwicklung
Wissenschaft·28.04.2026KI-Zusammenfassung
Chinese Scientists Develop Gene Therapy CS-101 Curing Five Beta-Thalassaemia Patients
Scientists at ShanghaiTech University have developed CS-101, a base-editing gene therapy that successfully cured five Chinese patients with beta-thalassaemia. The treatment restored haematopoietic function, raising total haemoglobin and fetal haemoglobin levels, freeing patients from lifelong blood transfusions. China has 30 million thalassaemia gene carriers while the global total reaches 350 million.
S
SCMP Economy